Sterling Research Group

Top Publications

Top Publications Authored or Co-Authored in "Sterling Research Group"

• A 52-week placebo-controlled trial of evolocumab in hyperlipidemia

  New England Journal of Medicine, Volume 370, No. 19, Year 2014, Citations 620
• Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: Pooled analysis of 1359 patients in four phase 2 trials

  European Heart Journal, Volume 35, No. 33, Year 2014, Citations 125
• Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome

  Diabetes, Obesity and Metabolism, Volume 19, No. 1, Year 2017, Citations 55
• Effects of evolocumab on Vitamin E and steroid hormone levels: Results from the 52-week, phase 3, double-blind, randomized,placebo-controlled DESCARTES study

  Circulation Research, Volume 117, No. 8, Year 2015, Citations 14